Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these https://lucbqrm423742.blogsvila.com/36407780/tirzepatide-a-promising-new-treatment-for-obesity